Self-expanding TAVR as good as surgery in intermediate-risk patients

Two-year data reveal no difference in the combined rate of stroke and death from any cause when comparing the use of self-expanding transcatheter aortic valve replacement (TAVR) with standard open-heart surgery in intermediate risk patients with severe aortic stenosis, according to research.
Source: ScienceDaily Headlines - Category: Science Source Type: news